{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:04:30Z","timestamp":1791338670193,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epstein-Barr virus (EBV) was identified as the first human virus to be associated with a human malignancy, Burkitt\u2019s lymphoma (BL), a pediatric cancer endemic in sub-Saharan Africa. The exact mechanism of how EBV contributes to the process of lymphomagenesis is not fully understood. Recent studies have highlighted a genetic difference between endemic (EBV+) and sporadic (EBV\u2212) BL, with the endemic variant showing a lower somatic mutation load, which suggests the involvement of an alternative virally-driven process of transformation in the pathogenesis of endemic BL. We tested the hypothesis that a global change in DNA methylation may be induced by infection with EBV, possibly thereby accounting for the lower mutation load observed in endemic BL. Our comparative analysis of the methylation profiles of a panel of BL derived cell lines, naturally infected or not with EBV, revealed that the presence of the virus is associated with a specific pattern of DNA methylation resulting in altered expression of cellular genes with a known or potential role in lymphomagenesis. These included ID3, a gene often found to be mutated in sporadic BL. In summary this study provides evidence that EBV may contribute to the pathogenesis of BL through an epigenetic mechanism.<\/jats:p>","DOI":"10.1038\/s41598-017-05713-2","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T11:20:43Z","timestamp":1499944843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines"],"prefix":"10.1038","volume":"7","author":[{"given":"Hector","family":"Hernandez-Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Gruffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Pierre","family":"Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Diederichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cilia","family":"Sirand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina C.","family":"Vargas-Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Le Calvez-Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenko","family":"Herceg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Manet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Tommasino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"Accardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"5713_CR1","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A review of human carcinogens. Volume 100B: Biological agents. IARC Monogr Eval Carcinog Risks Hum. (Lyon, International Agency for Research on Cancer, 1\u2013441, 2012)."},{"key":"5713_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A., Achong, B. G. & Barr, Y. M. Virus Particles in Cultured Lymphoblasts from Burkitt\u2019s Lymphoma. Lancet \n                           1, 702\u2013703 (1964).","journal-title":"Lancet"},{"key":"5713_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coviro.2016.09.006","volume":"20","author":"AM Moormann","year":"2016","unstructured":"Moormann, A. M. & Bailey, J. A. Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis. Current opinion in virology \n                           20, 78\u201384, doi:10.1016\/j.coviro.2016.09.006 (2016).","journal-title":"Current opinion in virology"},{"key":"5713_CR4","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/infdis\/jir872","volume":"205","author":"E Piriou","year":"2012","unstructured":"Piriou, E. et al. Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis \n                           205, 906\u2013913, doi:10.1093\/infdis\/jir872 (2012).","journal-title":"J Infect Dis"},{"key":"5713_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1086\/511984","volume":"195","author":"AM Moormann","year":"2007","unstructured":"Moormann, A. M. et al. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis \n                           195, 799\u2013808, doi:10.1086\/511984 (2007).","journal-title":"J Infect Dis"},{"key":"5713_CR6","doi-asserted-by":"publisher","first-page":"e1004170","DOI":"10.1371\/journal.ppat.1004170","volume":"10","author":"C Torgbor","year":"2014","unstructured":"Torgbor, C. et al. A multifactorial role for P. falciparum malaria in endemic Burkitt\u2019s lymphoma pathogenesis. PLoS Pathog \n                           10, e1004170, doi:10.1371\/journal.ppat.1004170 (2014).","journal-title":"PLoS Pathog"},{"key":"5713_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0042-6822(79)90455-0","volume":"94","author":"J Luka","year":"1979","unstructured":"Luka, J., Kallin, B. & Klein, G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology \n                           94, 228\u2013231 (1979).","journal-title":"Virology"},{"key":"5713_CR8","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1158\/0008-5472.CAN-08-3301","volume":"68","author":"RT Javier","year":"2008","unstructured":"Javier, R. T. & Butel, J. S. The history of tumor virology. Cancer Res \n                           68, 7693\u20137706, doi:10.1158\/0008-5472.CAN-08-3301 (2008).","journal-title":"Cancer Res"},{"key":"5713_CR9","doi-asserted-by":"publisher","first-page":"9593","DOI":"10.1073\/pnas.1202910109","volume":"109","author":"AR Marquitz","year":"2012","unstructured":"Marquitz, A. R., Mathur, A., Shair, K. H. & Raab-Traub, N. Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression. Proc Natl Acad Sci USA \n                           109, 9593\u20139598, doi:10.1073\/pnas.1202910109 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"5713_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love, C. et al. The genetic landscape of mutations in Burkitt lymphoma. Nature genetics \n                           44, 1321\u20131325, doi:10.1038\/ng.2468 (2012).","journal-title":"Nature genetics"},{"key":"5713_CR11","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.2469","volume":"44","author":"J Richter","year":"2012","unstructured":"Richter, J. et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nature genetics \n                           44, 1316\u20131320, doi:10.1038\/ng.2469 (2012).","journal-title":"Nature genetics"},{"key":"5713_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature \n                           490, 116\u2013120, doi:10.1038\/nature11378 (2012).","journal-title":"Nature"},{"key":"5713_CR13","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1182\/blood-2010-03-274506","volume":"116","author":"J Li","year":"2010","unstructured":"Li, J. et al. Mutation of inhibitory helix-loop-helix protein Id3 causes gammadelta T-cell lymphoma in mice. Blood \n                           116, 5615\u20135621, doi:10.1182\/blood-2010-03-274506 (2010).","journal-title":"Blood"},{"key":"5713_CR14","doi-asserted-by":"publisher","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","volume":"11","author":"F Abate","year":"2015","unstructured":"Abate, F. et al. Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. PLoS Pathog \n                           11, e1005158, doi:10.1371\/journal.ppat.1005158 (2015).","journal-title":"PLoS Pathog"},{"key":"5713_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.tim.2010.07.003","volume":"18","author":"K Paschos","year":"2010","unstructured":"Paschos, K. & Allday, M. J. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends in microbiology \n                           18, 439\u2013447, doi:10.1016\/j.tim.2010.07.003 (2010).","journal-title":"Trends in microbiology"},{"key":"5713_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mrrev.2011.04.001","volume":"727","author":"Z Herceg","year":"2011","unstructured":"Herceg, Z. & Paliwal, A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutation research \n                           727, 55\u201361, doi:10.1016\/j.mrrev.2011.04.001 (2011).","journal-title":"Mutation research"},{"key":"5713_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/655398","volume":"202","author":"P Kaur","year":"2010","unstructured":"Kaur, P. et al. DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection. J Infect Dis \n                           202, 700\u2013704, doi:10.1086\/655398 (2010).","journal-title":"J Infect Dis"},{"key":"5713_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13073-016-0267-2","volume":"8","author":"N Hattori","year":"2016","unstructured":"Hattori, N. & Ushijima, T. Epigenetic impact of infection on carcinogenesis: mechanisms and applications. Genome medicine \n                           8, 10, doi:10.1186\/s13073-016-0267-2 (2016).","journal-title":"Genome medicine"},{"key":"5713_CR19","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1016\/S0021-9258(18)53440-2","volume":"268","author":"J Staudinger","year":"1993","unstructured":"Staudinger, J., Perry, M., Elledge, S. J. & Olson, E. N. Interactions among vertebrate helix-loop-helix proteins in yeast using the two-hybrid system. J Biol Chem \n                           268, 4608\u20134611 (1993).","journal-title":"J Biol Chem"},{"key":"5713_CR20","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel, M. et al. A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. The New England journal of medicine \n                           354, 2419\u20132430, doi:10.1056\/NEJMoa055351 (2006).","journal-title":"The New England journal of medicine"},{"key":"5713_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2141.2011.08883.x","volume":"155","author":"JD Schiffman","year":"2011","unstructured":"Schiffman, J. D. et al. Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression. British journal of haematology \n                           155, 477\u2013486, doi:10.1111\/j.1365-2141.2011.08883.x (2011).","journal-title":"British journal of haematology"},{"key":"5713_CR22","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-11-3919","volume":"72","author":"A Kaneda","year":"2012","unstructured":"Kaneda, A., Matsusaka, K., Aburatani, H. & Fukayama, M. Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res \n                           72, 3445\u20133450, doi:10.1158\/0008-5472.CAN-11-3919 (2012).","journal-title":"Cancer Res"},{"key":"5713_CR23","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.3748\/wjg.v20.i14.3916","volume":"20","author":"K Matsusaka","year":"2014","unstructured":"Matsusaka, K., Funata, S., Fukayama, M. & Kaneda, A. DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. World journal of gastroenterology \n                           20, 3916\u20133926, doi:10.3748\/wjg.v20.i14.3916 (2014).","journal-title":"World journal of gastroenterology"},{"key":"5713_CR24","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.3748\/wjg.v20.i21.6448","volume":"20","author":"TO Yau","year":"2014","unstructured":"Yau, T. O., Tang, C. M. & Yu, J. Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: disease and treatments. World journal of gastroenterology \n                           20, 6448\u20136456, doi:10.3748\/wjg.v20.i21.6448 (2014).","journal-title":"World journal of gastroenterology"},{"key":"5713_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/cncr.21789","volume":"106","author":"M Kusano","year":"2006","unstructured":"Kusano, M. et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer \n                           106, 1467\u20131479, doi:10.1002\/cncr.21789 (2006).","journal-title":"Cancer"},{"key":"5713_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/cas.12228","volume":"104","author":"T Okada","year":"2013","unstructured":"Okada, T. et al. Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas. Cancer science \n                           104, 1309\u20131314, doi:10.1111\/cas.12228 (2013).","journal-title":"Cancer science"},{"key":"5713_CR27","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1093\/nar\/gks391","volume":"40","author":"K Paschos","year":"2012","unstructured":"Paschos, K., Parker, G. A., Watanatanasup, E., White, R. E. & Allday, M. J. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res \n                           40, 7233\u20137246, doi:10.1093\/nar\/gks391 (2012).","journal-title":"Nucleic Acids Res"},{"key":"5713_CR28","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1038\/bcj.2014.75","volume":"4","author":"T Zhang","year":"2014","unstructured":"Zhang, T. et al. Hypermethylation of the tumor suppressor gene PRDM1\/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma. Blood cancer journal \n                           4, e261, doi:10.1038\/bcj.2014.75 (2014).","journal-title":"Blood cancer journal"},{"key":"5713_CR29","doi-asserted-by":"publisher","first-page":"e6986","DOI":"10.1371\/journal.pone.0006986","volume":"4","author":"JI Martin-Subero","year":"2009","unstructured":"Martin-Subero, J. I. et al. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One \n                           4, e6986, doi:10.1371\/journal.pone.0006986 (2009).","journal-title":"PLoS One"},{"key":"5713_CR30","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1182\/blood-2008-04-152900","volume":"113","author":"JI Martin-Subero","year":"2009","unstructured":"Martin-Subero, J. I. et al. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood \n                           113, 2488\u20132497, doi:10.1182\/blood-2008-04-152900 (2009).","journal-title":"Blood"},{"key":"5713_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fgene.2014.00367","volume":"5","author":"HH Niller","year":"2014","unstructured":"Niller, H. H., Szenthe, K. & Minarovits, J. Epstein-Barr virus-host cell interactions: an epigenetic dialog? Frontiers in genetics \n                           5, 367, doi:10.3389\/fgene.2014.00367 (2014).","journal-title":"Frontiers in genetics"},{"key":"5713_CR32","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/leu.2013.4","volume":"27","author":"B Kreck","year":"2013","unstructured":"Kreck, B. et al. Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing. Leukemia \n                           27, 1751\u20131753, doi:10.1038\/leu.2013.4 (2013).","journal-title":"Leukemia"},{"key":"5713_CR33","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.semcancer.2013.09.001","volume":"23","author":"CU Niemann","year":"2013","unstructured":"Niemann, C. U. & Wiestner, A. B-cell receptor signaling as a driver of lymphoma development and evolution. Semin Cancer Biol \n                           23, 410\u2013421, doi:10.1016\/j.semcancer.2013.09.001 (2013).","journal-title":"Semin Cancer Biol"},{"key":"5713_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.seminhematol.2014.05.007","volume":"51","author":"Y Zhong","year":"2014","unstructured":"Zhong, Y., Byrd, J. C. & Dubovsky, J. A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology. Seminars in hematology \n                           51, 206\u2013218, doi:10.1053\/j.seminhematol.2014.05.007 (2014).","journal-title":"Seminars in hematology"},{"key":"5713_CR35","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.leukres.2008.09.016","volume":"33","author":"F He","year":"2009","unstructured":"He, F. et al. Notch and BCR signaling synergistically promote the proliferation of Raji B-lymphoma cells. Leukemia research \n                           33, 798\u2013802, doi:10.1016\/j.leukres.2008.09.016 (2009).","journal-title":"Leukemia research"},{"key":"5713_CR36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W Beguelin","year":"2013","unstructured":"Beguelin, W. et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer cell \n                           23, 677\u2013692, doi:10.1016\/j.ccr.2013.04.011 (2013).","journal-title":"Cancer cell"},{"key":"5713_CR37","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1182\/blood-2012-12-473439","volume":"123","author":"T Berg","year":"2014","unstructured":"Berg, T. et al. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis. Blood \n                           123, 3914\u20133924, doi:10.1182\/blood-2012-12-473439 (2014).","journal-title":"Blood"},{"key":"5713_CR38","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vire","year":"2006","unstructured":"Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature \n                           439, 871\u2013874, doi:10.1038\/nature04431 (2006).","journal-title":"Nature"},{"key":"5713_CR39","doi-asserted-by":"publisher","first-page":"9568","DOI":"10.1128\/JVI.00468-11","volume":"85","author":"S Leonard","year":"2011","unstructured":"Leonard, S. et al. Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin\u2019s lymphoma. J Virol \n                           85, 9568\u20139577, doi:10.1128\/JVI.00468-11 (2011).","journal-title":"J Virol"},{"key":"5713_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0092-8674(90)90214-Y","volume":"61","author":"R Benezra","year":"1990","unstructured":"Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. & Weintraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell \n                           61, 49\u201359 (1990).","journal-title":"Cell"},{"key":"5713_CR41","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1242\/jcs.000067","volume":"120","author":"M Hayashi","year":"2007","unstructured":"Hayashi, M. et al. Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling. J Cell Sci \n                           120, 1350\u20131357, doi:10.1242\/jcs.000067 (2007).","journal-title":"J Cell Sci"},{"key":"5713_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bcmd.2009.01.013","volume":"43","author":"K Blyth","year":"2009","unstructured":"Blyth, K. et al. Runx1 promotes B-cell survival and lymphoma development. Blood cells, molecules & diseases \n                           43, 12\u201319, doi:10.1016\/j.bcmd.2009.01.013 (2009).","journal-title":"Blood cells, molecules & diseases"},{"key":"5713_CR43","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI84014","volume":"126","author":"J Andricovich","year":"2016","unstructured":"Andricovich, J., Kai, Y., Peng, W., Foudi, A. & Tzatsos, A. Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis. The Journal of clinical investigation \n                           126, 905\u2013920, doi:10.1172\/JCI84014 (2016).","journal-title":"The Journal of clinical investigation"},{"key":"5713_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ncb2702","volume":"15","author":"J He","year":"2013","unstructured":"He, J. et al. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes. Nature cell biology \n                           15, 373\u2013384, doi:10.1038\/ncb2702 (2013).","journal-title":"Nature cell biology"},{"key":"5713_CR45","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/carcin\/bgv142","volume":"36","author":"R Accardi","year":"2015","unstructured":"Accardi, R. et al. The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in in vitro and in vivo experimental models. Carcinogenesis \n                           36, 1440\u20131451, doi:10.1093\/carcin\/bgv142 (2015).","journal-title":"Carcinogenesis"},{"key":"5713_CR46","doi-asserted-by":"publisher","first-page":"e9749","DOI":"10.1371\/journal.pone.0009749","volume":"5","author":"H Hernandez-Vargas","year":"2010","unstructured":"Hernandez-Vargas, H. et al. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One \n                           5, e9749, doi:10.1371\/journal.pone.0009749 (2010).","journal-title":"PLoS One"},{"key":"5713_CR47","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ygeno.2011.07.007","volume":"98","author":"M Bibikova","year":"2011","unstructured":"Bibikova, M. et al. High density DNA methylation array with single CpG site resolution. Genomics \n                           98, 288\u2013295, doi:10.1016\/j.ygeno.2011.07.007 (2011).","journal-title":"Genomics"},{"key":"5713_CR48","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics (Oxford, England) \n                           24, 1547\u20131548, doi:10.1093\/bioinformatics\/btn224 (2008).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"5713_CR49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2164-14-293","volume":"14","author":"R Pidsley","year":"2013","unstructured":"Pidsley, R. et al. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC genomics \n                           14, 293, doi:10.1186\/1471-2164-14-293 (2013).","journal-title":"BMC genomics"},{"key":"5713_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"YA Chen","year":"2013","unstructured":"Chen, Y. A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics \n                           8, 203\u2013209, doi:10.4161\/epi.23470 (2013).","journal-title":"Epigenetics"},{"key":"5713_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff, A. E. et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics (Oxford, England) \n                           29, 189\u2013196, doi:10.1093\/bioinformatics\/bts680 (2013).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"5713_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du, P. et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC bioinformatics \n                           11, 587, doi:10.1186\/1471-2105-11-587 (2010).","journal-title":"BMC bioinformatics"},{"key":"5713_CR53","doi-asserted-by":"publisher","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology \n                           3, Article3, doi:10.2202\/1544-6115.1027 (2004).","journal-title":"Statistical applications in genetics and molecular biology"},{"key":"5713_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-8935-8-6","volume":"8","author":"TJ Peters","year":"2015","unstructured":"Peters, T. J. et al. De novo identification of differentially methylated regions in the human genome. Epigenetics & chromatin \n                           8, 6, doi:10.1186\/1756-8935-8-6 (2015).","journal-title":"Epigenetics & chromatin"},{"key":"5713_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC bioinformatics \n                           14, 128, doi:10.1186\/1471-2105-14-128 (2013).","journal-title":"BMC bioinformatics"},{"key":"5713_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2164-14-139","volume":"14","author":"M Ouzounova","year":"2013","unstructured":"Ouzounova, M. et al. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC genomics \n                           14, 139, doi:10.1186\/1471-2164-14-139 (2013).","journal-title":"BMC genomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05713-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05713-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05713-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:04:49Z","timestamp":1671779089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05713-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["5713"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-05713-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]},"assertion":[{"value":"6 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5852"}}